Effects of flunixin meglumine on jejunal blood flow, motility, and oxygen consumption in ponies.

The research article explores the effects of flunixin meglumine (a drug commonly used in veterinary medicine) on intestinal blood flow, movement, and oxygen consumption in ponies. Interestingly, the drug was found to increase systemic arterial pressure and intestinal vascular resistance, without negatively impacting the overall health and function of the intestine.

Methodology

• The study centered on the effects of flunixin meglumine on ten anesthetized ponies. The ponies were ventilated with a mixture of halothane and oxygen for the duration of the study.
• Using isolated autoperfused intestinal segments, the researchers assessed how this drug impacts systemic arterial blood pressure, blood flow in the jejunum (a part of the small intestine), vascular resistance, intestinal motility (movement), arteriovenous oxygen difference (the difference in oxygen content between arterial and venous blood), and oxygen consumption.
• A saline solution or flunixin meglumine was administered as a single bolus into the left jugular vein of the ponies. The dosage of flunixin meglumine was 1.1 mg per kg of body weight.

Findings

• The study found that within 10 minutes of flunixin meglumine administration, there was an increase in systemic arterial blood pressure and intestinal vascular resistance.
• However, the blood flow in the jejunum was not significantly reduced until an hour after the drug was administered.
• There were no considerable changes spotted in intestinal motility, arteriovenous oxygen difference, and oxygen consumption after the administration of flunixin meglumine.
• The results signified that although flunixin meglumine increases systemic arterial pressure and intestinal vascular resistance, it does not lead to the compromise of intestinal viability, meaning it does not severely affect the normal, healthy function of the intestine.

Conclusion

• This investigation highlights the capabilities and potential effects of flunixin meglumine on ponies. In particular, the drug can increase the systemic arterial pressure and intestinal vascular resistance without compromising the health and operation of the intestines.
• These findings contribute significantly to veterinary medicine, potentially guiding more efficient and safer use of flunixin meglumine in treating animals, particularly equines.